Literature DB >> 11137224

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

P Paul1, N Rouas-Freiss, P Moreau, F A Cabestre, C Menier, I Khalil-Daher, C Pangault, M Onno, R Fauchet, J Martinez-Laso, P Morales, A A Villena, P Giacomini, P G Natali, G Frumento, G B Ferrara, M McMaster, S Fisher, D Schust, S Ferrone, J Dausset, D Geraghty, E D Carosella.   

Abstract

Non-classical MHC class I HLA-E, -F, and -G molecules differ from classical class I histocompatibility antigens by specific patterns of transcription, protein expression, and immunological functions. Restriction of the expression pattern of these non-classical antigens may play a key role in modulation of immune responses during pregnancy and diseases but remains to be additionally defined. A specific component of the second International Conference on HLA-G and the 13th HLA-G Histocompatibility Workshop will be dedicated to the analysis of transcription and expression of non-classical class I genes in normal and pathological tissues. In a first step, referred to as the preworkshop, we here report the analysis and conclusions of a working group which was constituted to gather and validate optimal reagents and protocols allowing RT-PCR analysis of HLA-E, -F, -G transcript levels and flow cytometry and immunochemistry analysis of HLA-G expression in cells and tissues. As a result of this work, use of specific primers and probes detecting alternative transcripts of HLA-E, -F, and G have been validated in transfected cells expressing differential pattern of HLA class I antigens. Analysis of the specificity and affinity of collected antibodies has allowed definition of reagents to be proposed for immunochemistry and flow cytometry analysis of HLA-G expression in normal and pathological tissues during the workshop. This work has allowed constitution of an extended workshop group which is now initiating analysis of non-classical class I transcription and expression in various cells and tissues, a collective contribution that will additionally refine our view of the expression of these antigens in normal and pathological situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137224     DOI: 10.1016/s0198-8859(00)00154-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

1.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors.

Authors:  Kiave-Yune HoWangYin; Maria Loustau; Juan Wu; Estibaliz Alegre; Marina Daouya; Julien Caumartin; Sylvie Sousa; Anatolij Horuzsko; Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

3.  Increased human leukocyte antigen-G expression at the maternal-fetal interface is associated with preterm birth.

Authors:  Molly J Stout; Bin Cao; Michele Landeau; Jacob French; George A Macones; Indira U Mysorekar
Journal:  J Matern Fetal Neonatal Med       Date:  2014-05-29

4.  Soluble HLA-G induces NF-kappaB activation in natural killer cells.

Authors:  I Zidi; C Guillard; E D Carosella; P Moreau
Journal:  J Physiol Biochem       Date:  2010-04-20       Impact factor: 4.158

Review 5.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

6.  Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

Authors:  Solène Le Rond; Alvaro Gonzalez; Ana S L Gonzalez; Edgardo D Carosella; Nathalie Rouas-Freiss
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

7.  Expression of HLA-G in hemangioma and its clinical significance.

Authors:  Guang Shan; Tian Tang; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

8.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

Authors:  Lilach Kleinberg; Vivi Ann Flørenes; Martina Skrede; Hiep Phuc Dong; Søren Nielsen; Michael T McMaster; Jahn M Nesland; Ie-Ming Shih; Ben Davidson
Journal:  Virchows Arch       Date:  2006-03-16       Impact factor: 4.064

10.  HLA-G gene repression is reversed by demethylation.

Authors:  Philippe Moreau; Gael Mouillot; Philippe Rousseau; Celine Marcou; Jean Dausset; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.